Header Logo

Connection

HANUMANTHA PULIVARTHI to Nucleic Acid Hybridization

Back to Details
This is a "connection" page, showing publications HANUMANTHA PULIVARTHI has written about Nucleic Acid Hybridization.
HANUMANTHA PULIVARTHI
Connection Strength
1.103
Nucleic Acid Hybridization
  1. Comparative genomic hybridization for analysis of changes in DNA copy number in multiple myeloma. Methods Mol Med. 2005; 113:71-83.
    View in: PubMed
    Score: 0.219
  2. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas. J Clin Endocrinol Metab. 1998 May; 83(5):1766-70.
    View in: PubMed
    Score: 0.138
  3. Comparative genomic hybridization study of de novo myeloid neoplasia. Acta Haematol. 2000; 104(1):25-30.
    View in: PubMed
    Score: 0.078
  4. Overexpression of Separase induces aneuploidy and mammary tumorigenesis. Proc Natl Acad Sci U S A. 2008 Sep 02; 105(35):13033-8.
    View in: PubMed
    Score: 0.071
  5. Clinical utility of array comparative genomic hybridization for detection of chromosomal abnormalities in pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008 Aug; 51(2):171-7.
    View in: PubMed
    Score: 0.070
  6. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer. 2004 Aug 07; 4:45.
    View in: PubMed
    Score: 0.053
  7. Similar patterns of genomic alterations characterize primary mediastinal large-B-cell lymphoma and diffuse large-B-cell lymphoma. Genes Chromosomes Cancer. 2002 Feb; 33(2):114-22.
    View in: PubMed
    Score: 0.045
  8. Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma. Clin Cancer Res. 2007 Aug 01; 13(15 Pt 1):4386-91.
    View in: PubMed
    Score: 0.033
  9. Molecular cytogenetic applications in analysis of the cancer genome. Methods Mol Biol. 2007; 383:165-85.
    View in: PubMed
    Score: 0.031
  10. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung. Clin Cancer Res. 2004 Sep 01; 10(17):5792-803.
    View in: PubMed
    Score: 0.027
  11. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Genes Chromosomes Cancer. 2004 Aug; 40(4):355-64.
    View in: PubMed
    Score: 0.027
  12. Amplification of MGC2177, PLAG1, PSMC6P, and LYN in a malignant mixed tumor of salivary gland detected by cDNA microarray with tyramide signal amplification. Cancer Genet Cytogenet. 2004 Jul 15; 152(2):124-8.
    View in: PubMed
    Score: 0.027
  13. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer. 2004 Feb 06; 4:5.
    View in: PubMed
    Score: 0.026
  14. The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability. Proc Natl Acad Sci U S A. 2003 Sep 30; 100(20):11547-52.
    View in: PubMed
    Score: 0.025
  15. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chromosomes Cancer. 2003 Mar; 36(3):233-41.
    View in: PubMed
    Score: 0.024
  16. Genomic and expression analysis of the 12p11-p12 amplicon using EST arrays identifies two novel amplified and overexpressed genes. Cancer Res. 2002 Nov 01; 62(21):6218-23.
    View in: PubMed
    Score: 0.024
  17. Spectral karyotyping analysis of head and neck squamous cell carcinoma. Laryngoscope. 2001 Sep; 111(9):1545-50.
    View in: PubMed
    Score: 0.022
  18. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification. Cancer Res. 2001 Jun 01; 61(11):4506-13.
    View in: PubMed
    Score: 0.021
  19. Improving degenerate oligonucleotide primed PCR-comparative genomic hybridization for analysis of DNA copy number changes in tumors. Genes Chromosomes Cancer. 2000 Aug; 28(4):395-403.
    View in: PubMed
    Score: 0.020
  20. Genome-wide screening for radiation response factors in head and neck cancer. Laryngoscope. 2000 Aug; 110(8):1251-6.
    View in: PubMed
    Score: 0.020
  21. Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization. Blood. 1998 Apr 15; 91(8):3007-10.
    View in: PubMed
    Score: 0.017
  22. Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. J Clin Oncol. 2004 Oct 01; 22(19):3965-72.
    View in: PubMed
    Score: 0.013
  23. Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma. Genes Chromosomes Cancer. 2004 Jan; 39(1):11-21.
    View in: PubMed
    Score: 0.013
  24. Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud's syndrome: a case report emphasizing the cytological and cytogenetic findings. Hum Pathol. 2003 Dec; 34(12):1354-7.
    View in: PubMed
    Score: 0.013
  25. Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression. Oncogene. 2003 May 29; 22(22):3489-99.
    View in: PubMed
    Score: 0.012
  26. Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure. BMC Genet. 2002 Nov 14; 3:22.
    View in: PubMed
    Score: 0.012
  27. Genome-wide appraisal of thyroid cancer progression. Am J Pathol. 2002 Nov; 161(5):1549-56.
    View in: PubMed
    Score: 0.012
  28. Comparative genomic hybridization and amplotyping by arbitrarily primed PCR in stage A B-CLL. Cancer Genet Cytogenet. 2001 Oct 01; 130(1):8-13.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.